Formulary Search - PAD Formulary

PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > Formulary Search

BNF Chapter

BNF Paragraph

Please select a BNF Chapter.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results

Records returned : 29.

Guideline Profile : Antimicrobial guidelines
Guideline Profile : Blood Glucose Test Strips
Brand names include : GlucoRx Q, FineTest Lite, Wavesense JAZZ, 4SURE, CareSens Pro, GlucoRx HCT Glucose, GlucoRx HCT Ketone, CareSens KetoSens, 4SURE Beta-ketone, GlucoRx Nexus, Accu-chek Instant, Contour Plus, Contour Plus Blue
Guideline Profile : Genomic Medicine
Guideline Profile : Helicobacter pylori
Guideline Profile : Transgender Health - adults
Guideline Profile : Transgender Health - Children and Young People
Non Clinical Profile : Spirometry
Non Clinical Profile : Warfarin - INR Monitoring
Brand names include : CoaguChek, Lumira Dx INR test, MicroINR
Patch tests / prick tests - Allergen immunotherapy
Antimicrobial susceptability testing (AST) - Antimicrobial guidelines
Glucose, Lactose, Fructose and Lactulose - Breath test
Glucose - Diabetes Mellitus
Brand names include : Rapilose
Infloran - Gastrointestinal dysmicrobial syndromes
Other test for helicobacter pylori preparations - Helicobacter pylori
FreeStyle Libre 2 (Intermittently scanned continuous glucose monitoring) - Insulin treated Type II Diabetes patients living with a learning disability
Brand names include : FreeStyle Libre
Parenteral nutrition - Intestinal failure
Testosterone - Low sexual desire in menopausal women
Brand names include : Androfeme
Testosterone injection / implant - Male hypogonadism
Brand names include : Nebido, Sustanon
Hyoscine butylbromide - Muscle spasm
Brand names include : Buscopan
Mebeverine hydrochloride - Muscle spasm
Brand names include : Colofac
Peppermint oil - Muscle spasm
Brand names include : Mintec, Colpermin
Apomorphine hydrochloride - Parkinson's disease (challenge test)
Brand names include : APO-go, Dacepton
Co-beneldopa - Parkinson's disease (challenge test)
Brand names include : Madopar
Co-careldopa - Parkinson's disease (challenge test)
Brand names include : Sinemet, Sinemet CR, Sinemet Plus, Caramet, Half-Sinemet CR, Lecado, Duodopa, Apodespan
Salbutamol MDI - Reversibility testing
Regadenoson - Stress test
Abacavir and lamivudine - TEST
Testosterone - Transgender Health - adults
Brand names include : Sustanon 250, Nebido, Testogel, Tostran, Testavan
Testosterone - Transgender Health - Children & Young People
Brand names include : Tostran, Testogel, Sustanon 250

For information about the icons and status values within this site, please refer to the keys below.

Icon/Links Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

ICB

Treatment commissioned by the ICB

BlueTeq

BlueTeq form to be completed

NICE

Traffic Light Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Black

Now referred to as "Non Formulary" but some BLACK drugs remain pending review. Not recommended for use in any health setting across Surrey and NW Sussex health economy.

Amber Star

Now referred to as "Blue" but some Amber Star drugs remain pending review. Prescribing initiated and stabliised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across Surrey and NW Sussex health economy. (Formerly BLACK traffic light status)

See Below

Please add a description.

N/A

Please add a description.

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

Green - Black

Now referred to as "Do not initiate in new patients" but some GREEN/BLACK drugs remain pending review. These drugs are NOT for new initiations (BLACK, (now referred to as Non Formulary)) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required.

See narrative

See narrative - is applied in instances where there may be more than one traffic light status for a drug. This occurs when the traffic light status may differ between specific cohorts of patients e.g. those of childbearing potential and those who are not (in the case of sodium valproate)

Do not initiate in new patients

These drugs are NOT for new initiations (Non Formulary) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required. (Formerly GREEN/BLACK traffic light status)